Gebinate Plus Dry Syrup

Gebinate Plus Dry Syrup is a prescription medicine. It is to be taken with food and take it at a fixed time regularly. Take the medicine in the dose and duration advised by your doctor. Do not consume more than the recommended dose, as this may have harmful effects on your body. A missed dose should be taken as soon as you remember. The course of the treatment should be completed for better efficacy.

Some common side effects of this medicine are headaches, loss of appetite, weakness, pain in muscles, and joint pain. You may also feel dizzy, thus it is advised not to drive or operate machinery. To overcome dizziness you should drink plenty of fluid. If any of the side effects get aggravated, contact your doctor immediately.

Before taking this medicine, you should tell your doctor if you are taking any medication for any health conditions. Pregnant or breastfeeding women should also consult with their doctor before taking it. Avoid drinking alcohol as it can cause excessive drowsiness with this medicine.

Treatment of Malaria

Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Dissolve the powder in sterile water. Shake well and use. Gebinate Plus Dry Syrup is to be taken with food.

Gebinate Plus Dry Syrup is a combination of two antiparasitic medicines: Arteether and Lumefantrine, which treats malaria. These medicines work by increasing the levels of haeme in the blood, a substance toxic to the malarial parasite. This kills the parasite and stops the infection from spreading.

If you miss a dose of Gebinate Plus Dry Syrup, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Information not available at the moment. Please check back later.

Information not available at the moment. Please check back later.

In Treatment of Malaria

Malaria is a serious or life-threatening illness that is spread by a parasite that enters the human body by the bite of infected mosquitoes. Gebinate Plus Dry Syrup is an antimalarial medicine and is used to treat malaria. It kills the infection-causing parasite and stops the further spread of the infection in the body. Do not use this medicine for treating any other condition without consulting your doctor.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Joint pain

Muscle pain

Weakness

Dizziness

Loss of appetite

Headache

Alcohol:CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Gebinate Plus Dry Syrup. Please consult your doctor.

Pregnancy:CONSULT YOUR DOCTOR

Gebinate Plus Dry Syrup may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding:CONSULT YOUR DOCTOR

Information regarding the use of Gebinate Plus Dry Syrup during breastfeeding is not available. Please consult your doctor.

Driving:UNSAFE

Gebinate Plus Dry Syrup may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney:CAUTION

Gebinate Plus Dry Syrup should be used with caution in patients with severe kidney disease. Dose adjustment of Gebinate Plus Dry Syrup may be needed. Please consult your doctor.No dose adjustment is recommended in patients with severe kidney disease.

Liver:CAUTION

Gebinate Plus Dry Syrup should be used with caution in patients with severe liver disease. Dose adjustment of Gebinate Plus Dry Syrup may be needed. Please consult your doctor.No dose adjustment is recommended in patients with severe liver disease.

Mohanty S, Mishra S K, Satpathy SK. Comparison of Intramuscular Arteether and Intravenous Quinine for the Treatment of Cerebral Malaria. Journal of Indian Academy of Clinical Medicine. 2000;5:119-23. view

MedIndia. Arteethler. view

Lumefantrine. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2009 . view